APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimalarial Medication

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antimalarial Medication Market Analysis and Forecast 2026-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchAntimalarial Medication Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimalarial Medication Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Antimalarial Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimalarial Medication Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimalarial Medication Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Antimalarial Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antimalarial Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antimalarial Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antimalarial Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antimalarial Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antimalarial Medication include Sun Pharmaceutical Industries, Novartis, Merck, Pfizer, GlaxoSmithKline and F. Hoffmann-La Roche, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antimalarial Medication, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antimalarial Medication, also provides the sales of main regions and countries. Of the upcoming market potential for Antimalarial Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antimalarial Medication sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antimalarial Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antimalarial Medication sales, projected growth trends, production technology, application and end-user industry.

Antimalarial Medication Segment by Company

Sun Pharmaceutical Industries

Novartis

Merck

Pfizer

GlaxoSmithKline

F. Hoffmann-La Roche

Antimalarial Medication Segment by Type

Plasmodium Malariae

Plasmodium Ovale

Plasmodium Vivax

Plasmodium Falciparum

Antimalarial Medication Segment by Application

E- Commerce

Retail Pharmacy

Hospital Pharmacy

Others

Antimalarial Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimalarial Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimalarial Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimalarial Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antimalarial Medication in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antimalarial Medication manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antimalarial Medication sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antimalarial Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Plasmodium Malariae Major Manufacturers Table 3. Plasmodium Ovale Major Manufacturers Table 4. Plasmodium Vivax Major Manufacturers Table 5. Plasmodium Falciparum Major Manufacturers Table 6. Global Antimalarial Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. E- Commerce Major Manufacturers Table 8. Retail Pharmacy Major Manufacturers Table 9. Hospital Pharmacy Major Manufacturers Table 10. Others Major Manufacturers Table 11. Antimalarial Medication Industry Trends Table 12. Antimalarial Medication Industry Drivers Table 13. Antimalarial Medication Industry Opportunities and Challenges Table 14. Antimalarial Medication Industry Restraints Table 15. Global Antimalarial Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Antimalarial Medication Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Antimalarial Medication Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Antimalarial Medication Revenue Market Share by Region (2021-2026) Table 19. Global Antimalarial Medication Revenue Market Share by Region (2027-2032) Table 20. Global Antimalarial Medication Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Antimalarial Medication Sales by Region (2021-2026) & (K Units) Table 22. Global Antimalarial Medication Sales by Region (2027-2032) & (K Units) Table 23. Global Antimalarial Medication Sales Market Share by Region (2021-2026) Table 24. Global Antimalarial Medication Sales Market Share by Region (2027-2032) Table 25. Global Antimalarial Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Antimalarial Medication Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Antimalarial Medication Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Antimalarial Medication Sales Market Share by Manufacturers (2021-2026) Table 29. Global Antimalarial Medication Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Antimalarial Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Antimalarial Medication Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Antimalarial Medication Manufacturers, Product Type & Application Table 33. Global Antimalarial Medication Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Antimalarial Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Antimalarial Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Antimalarial Medication Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Antimalarial Medication Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Antimalarial Medication Revenue Market Share by Type (2021-2026) Table 40. Global Antimalarial Medication Revenue Market Share by Type (2027-2032) Table 41. Global Antimalarial Medication Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 43. Global Antimalarial Medication Sales by Type (2027-2032) & (K Units) Table 44. Global Antimalarial Medication Sales Market Share by Type (2021-2026) Table 45. Global Antimalarial Medication Sales Market Share by Type (2027-2032) Table 46. Global Antimalarial Medication Price by Type (2021-2026) & (US$/Unit) Table 47. Global Antimalarial Medication Price by Type (2027-2032) & (US$/Unit) Table 48. Global Antimalarial Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Antimalarial Medication Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Antimalarial Medication Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Antimalarial Medication Revenue Market Share by Application (2021-2026) Table 52. Global Antimalarial Medication Revenue Market Share by Application (2027-2032) Table 53. Global Antimalarial Medication Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 55. Global Antimalarial Medication Sales by Application (2027-2032) & (K Units) Table 56. Global Antimalarial Medication Sales Market Share by Application (2021-2026) Table 57. Global Antimalarial Medication Sales Market Share by Application (2027-2032) Table 58. Global Antimalarial Medication Price by Application (2021-2026) & (US$/Unit) Table 59. Global Antimalarial Medication Price by Application (2027-2032) & (US$/Unit) Table 60. Sun Pharmaceutical Industries Company Information Table 61. Sun Pharmaceutical Industries Business Overview Table 62. Sun Pharmaceutical Industries Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Sun Pharmaceutical Industries Antimalarial Medication Product Portfolio Table 64. Sun Pharmaceutical Industries Recent Development Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Novartis Antimalarial Medication Product Portfolio Table 69. Novartis Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Merck Antimalarial Medication Product Portfolio Table 74. Merck Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Pfizer Antimalarial Medication Product Portfolio Table 79. Pfizer Recent Development Table 80. GlaxoSmithKline Company Information Table 81. GlaxoSmithKline Business Overview Table 82. GlaxoSmithKline Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline Antimalarial Medication Product Portfolio Table 84. GlaxoSmithKline Recent Development Table 85. F. Hoffmann-La Roche Company Information Table 86. F. Hoffmann-La Roche Business Overview Table 87. F. Hoffmann-La Roche Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. F. Hoffmann-La Roche Antimalarial Medication Product Portfolio Table 89. F. Hoffmann-La Roche Recent Development Table 90. North America Antimalarial Medication Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Antimalarial Medication Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 93. North America Antimalarial Medication Sales by Type (2027-2032) & (K Units) Table 94. North America Antimalarial Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 95. North America Antimalarial Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 96. North America Antimalarial Medication Revenue by Application (2021-2026) & (US$ Million) Table 97. North America Antimalarial Medication Revenue by Application (2027-2032) & (US$ Million) Table 98. North America Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 99. North America Antimalarial Medication Sales by Application (2027-2032) & (K Units) Table 100. North America Antimalarial Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 101. North America Antimalarial Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 102. North America Antimalarial Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Antimalarial Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. North America Antimalarial Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. North America Antimalarial Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. North America Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 107. North America Antimalarial Medication Sales by Country (2027-2032) & (K Units) Table 108. North America Antimalarial Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 109. North America Antimalarial Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 110. United States Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 111. Canada Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 112. Europe Antimalarial Medication Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Antimalarial Medication Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 115. Europe Antimalarial Medication Sales by Type (2027-2032) & (K Units) Table 116. Europe Antimalarial Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 117. Europe Antimalarial Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 118. Europe Antimalarial Medication Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Antimalarial Medication Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 121. Europe Antimalarial Medication Sales by Application (2027-2032) & (K Units) Table 122. Europe Antimalarial Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 123. Europe Antimalarial Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 124. Europe Antimalarial Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Antimalarial Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. Europe Antimalarial Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. Europe Antimalarial Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. Europe Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 129. Europe Antimalarial Medication Sales by Country (2027-2032) & (K Units) Table 130. Europe Antimalarial Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 131. Europe Antimalarial Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 132. Germany Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 133. France Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 134. U.K. Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 135. Italy Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 137. Nordic Countries Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 138. China Antimalarial Medication Revenue by Type (2021-2026) & (US$ Million) Table 139. China Antimalarial Medication Revenue by Type (2027-2032) & (US$ Million) Table 140. China Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 141. China Antimalarial Medication Sales by Type (2027-2032) & (K Units) Table 142. China Antimalarial Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 143. China Antimalarial Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 144. China Antimalarial Medication Revenue by Application (2021-2026) & (US$ Million) Table 145. China Antimalarial Medication Revenue by Application (2027-2032) & (US$ Million) Table 146. China Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 147. China Antimalarial Medication Sales by Application (2027-2032) & (K Units) Table 148. China Antimalarial Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 149. China Antimalarial Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 150. Asia Antimalarial Medication Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia Antimalarial Medication Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 153. Asia Antimalarial Medication Sales by Type (2027-2032) & (K Units) Table 154. Asia Antimalarial Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 155. Asia Antimalarial Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 156. Asia Antimalarial Medication Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Antimalarial Medication Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 159. Asia Antimalarial Medication Sales by Application (2027-2032) & (K Units) Table 160. Asia Antimalarial Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 161. Asia Antimalarial Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia Antimalarial Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Antimalarial Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Asia Antimalarial Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Asia Antimalarial Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 166. Asia Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 167. Asia Antimalarial Medication Sales by Country (2027-2032) & (K Units) Table 168. Asia Antimalarial Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 169. Asia Antimalarial Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 170. Japan Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 171. South Korea Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 172. India Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 173. Australia Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 174. China Taiwan Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 175. Southeast Asia Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 176. SAMEA Antimalarial Medication Revenue by Type (2021-2026) & (US$ Million) Table 177. SAMEA Antimalarial Medication Revenue by Type (2027-2032) & (US$ Million) Table 178. SAMEA Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 179. SAMEA Antimalarial Medication Sales by Type (2027-2032) & (K Units) Table 180. SAMEA Antimalarial Medication Sales Price by Type (2021-2026) & (US$/Unit) Table 181. SAMEA Antimalarial Medication Sales Price by Type (2027-2032) & (US$/Unit) Table 182. SAMEA Antimalarial Medication Revenue by Application (2021-2026) & (US$ Million) Table 183. SAMEA Antimalarial Medication Revenue by Application (2027-2032) & (US$ Million) Table 184. SAMEA Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 185. SAMEA Antimalarial Medication Sales by Application (2027-2032) & (K Units) Table 186. SAMEA Antimalarial Medication Sales Price by Application (2021-2026) & (US$/Unit) Table 187. SAMEA Antimalarial Medication Sales Price by Application (2027-2032) & (US$/Unit) Table 188. SAMEA Antimalarial Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. SAMEA Antimalarial Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. SAMEA Antimalarial Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. SAMEA Antimalarial Medication Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 192. SAMEA Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 193. SAMEA Antimalarial Medication Sales by Country (2027-2032) & (K Units) Table 194. SAMEA Antimalarial Medication Sales Price by Country (2021-2026) & (US$/Unit) Table 195. SAMEA Antimalarial Medication Sales Price by Country (2027-2032) & (US$/Unit) Table 196. Brazil Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 197. Argentina Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 198. Chile Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 199. Colombia Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 200. Peru Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 201. Saudi Arabia Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 202. Israel Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 203. UAE Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 204. Turkey Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 205. Iran Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 206. Egypt Antimalarial Medication Revenue (2021-2032) & (US$ Million) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Antimalarial Medication Distributors List Table 210. Antimalarial Medication Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Antimalarial Medication Image Figure 2. Global Antimalarial Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimalarial Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Plasmodium Malariae Image Figure 5. Plasmodium Ovale Image Figure 6. Plasmodium Vivax Image Figure 7. Plasmodium Falciparum Image Figure 8. Global Antimalarial Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Antimalarial Medication Market Size Share 2021 VS 2025 VS 2032 Figure 10. E- Commerce Image Figure 11. Retail Pharmacy Image Figure 12. Hospital Pharmacy Image Figure 13. Others Image Figure 14. Global Antimalarial Medication Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Antimalarial Medication Revenue (2021-2032) & (US$ Million) Figure 16. Global Antimalarial Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Antimalarial Medication Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Antimalarial Medication Revenue Market Share by Region (2021-2032) Figure 19. Global Antimalarial Medication Sales (2021-2032) & (K Units) Figure 20. Global Antimalarial Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Antimalarial Medication Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Antimalarial Medication Sales YoY (2021-2032) & (K Units) Figure 23. Europe Antimalarial Medication Sales YoY (2021-2032) & (K Units) Figure 24. China Antimalarial Medication Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Antimalarial Medication Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Antimalarial Medication Sales YoY (2021-2032) & (K Units) Figure 27. Global Antimalarial Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Antimalarial Medication Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Antimalarial Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Antimalarial Medication Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Antimalarial Medication Revenue Market Share by Type (2021-2032) Figure 33. Global Antimalarial Medication Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Antimalarial Medication Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Antimalarial Medication Sales Market Share by Type (2021-2032) Figure 36. Global Antimalarial Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Antimalarial Medication Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Antimalarial Medication Revenue Market Share by Application (2021-2032) Figure 39. Global Antimalarial Medication Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Antimalarial Medication Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Antimalarial Medication Sales Market Share by Application (2021-2032) Figure 42. North America Antimalarial Medication Revenue Share by Type (2021-2032) Figure 43. North America Antimalarial Medication Sales Share by Type (2021-2032) Figure 44. North America Antimalarial Medication Revenue Share by Application (2021-2032) Figure 45. North America Antimalarial Medication Sales Share by Application (2021-2032) Figure 46. North America Antimalarial Medication Revenue Share by Country (2021-2032) Figure 47. North America Antimalarial Medication Sales Share by Country (2021-2032) Figure 48. Europe Antimalarial Medication Revenue Share by Type (2021-2032) Figure 49. Europe Antimalarial Medication Sales Share by Type (2021-2032) Figure 50. Europe Antimalarial Medication Revenue Share by Application (2021-2032) Figure 51. Europe Antimalarial Medication Sales Share by Application (2021-2032) Figure 52. Europe Antimalarial Medication Revenue Share by Country (2021-2032) Figure 53. Europe Antimalarial Medication Sales Share by Country (2021-2032) Figure 54. China Antimalarial Medication Revenue Share by Type (2021-2032) Figure 55. China Antimalarial Medication Sales Share by Type (2021-2032) Figure 56. China Antimalarial Medication Revenue Share by Application (2021-2032) Figure 57. China Antimalarial Medication Sales Share by Application (2021-2032) Figure 58. Asia Antimalarial Medication Revenue Share by Type (2021-2032) Figure 59. Asia Antimalarial Medication Sales Share by Type (2021-2032) Figure 60. Asia Antimalarial Medication Revenue Share by Application (2021-2032) Figure 61. Asia Antimalarial Medication Sales Share by Application (2021-2032) Figure 62. Asia Antimalarial Medication Revenue Share by Country (2021-2032) Figure 63. Asia Antimalarial Medication Sales Share by Country (2021-2032) Figure 64. SAMEA Antimalarial Medication Revenue Share by Type (2021-2032) Figure 65. SAMEA Antimalarial Medication Sales Share by Type (2021-2032) Figure 66. SAMEA Antimalarial Medication Revenue Share by Application (2021-2032) Figure 67. SAMEA Antimalarial Medication Sales Share by Application (2021-2032) Figure 68. SAMEA Antimalarial Medication Revenue Share by Country (2021-2032) Figure 69. SAMEA Antimalarial Medication Sales Share by Country (2021-2032) Figure 70. Antimalarial Medication Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Antimalarial Medication Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmodium Malariae
  • Plasmodium Ovale
  • Plasmodium Vivax
  • Plasmodium Falciparum
Applications
  • E- Commerce
  • Retail Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • F. Hoffmann-La Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antimalarial Medication Market by Type
  3. 1.2.1 Global Antimalarial Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Plasmodium Malariae
  5. 1.2.3 Plasmodium Ovale
  6. 1.2.4 Plasmodium Vivax
  7. 1.2.5 Plasmodium Falciparum
  8. 1.3 Antimalarial Medication Market by Application
  9. 1.3.1 Global Antimalarial Medication Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 E- Commerce
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Hospital Pharmacy
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Antimalarial Medication Market Dynamics
  1. 2.1 Antimalarial Medication Industry Trends
  2. 2.2 Antimalarial Medication Industry Drivers
  3. 2.3 Antimalarial Medication Industry Opportunities and Challenges
  4. 2.4 Antimalarial Medication Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antimalarial Medication Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antimalarial Medication Revenue by Region
  3. 3.2.1 Global Antimalarial Medication Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antimalarial Medication Revenue by Region (2021-2026)
  5. 3.2.3 Global Antimalarial Medication Revenue by Region (2027-2032)
  6. 3.2.4 Global Antimalarial Medication Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antimalarial Medication Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antimalarial Medication Sales by Region
  9. 3.4.1 Global Antimalarial Medication Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antimalarial Medication Sales by Region (2021-2026)
  11. 3.4.3 Global Antimalarial Medication Sales by Region (2027-2032)
  12. 3.4.4 Global Antimalarial Medication Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antimalarial Medication Revenue by Manufacturers
  2. 4.1.1 Global Antimalarial Medication Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antimalarial Medication Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antimalarial Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antimalarial Medication Sales by Manufacturers
  6. 4.2.1 Global Antimalarial Medication Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antimalarial Medication Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antimalarial Medication Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antimalarial Medication Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antimalarial Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antimalarial Medication Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antimalarial Medication Manufacturers, Product Type & Application
  13. 4.7 Global Antimalarial Medication Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antimalarial Medication Market CR5 and HHI
  16. 4.8.2 2025 Antimalarial Medication Tier 1, Tier 2, and Tier 3
5 Antimalarial Medication Market by Type
  1. 5.1 Global Antimalarial Medication Revenue by Type
  2. 5.1.1 Global Antimalarial Medication Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antimalarial Medication Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antimalarial Medication Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antimalarial Medication Sales by Type
  6. 5.2.1 Global Antimalarial Medication Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antimalarial Medication Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Antimalarial Medication Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antimalarial Medication Price by Type
6 Antimalarial Medication Market by Application
  1. 6.1 Global Antimalarial Medication Revenue by Application
  2. 6.1.1 Global Antimalarial Medication Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antimalarial Medication Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antimalarial Medication Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antimalarial Medication Sales by Application
  6. 6.2.1 Global Antimalarial Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antimalarial Medication Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Antimalarial Medication Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antimalarial Medication Price by Application
7 Company Profiles
  1. 7.1 Sun Pharmaceutical Industries
  2. 7.1.1 Sun Pharmaceutical Industries Company Information
  3. 7.1.2 Sun Pharmaceutical Industries Business Overview
  4. 7.1.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharmaceutical Industries Antimalarial Medication Product Portfolio
  6. 7.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Antimalarial Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Antimalarial Medication Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Antimalarial Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Antimalarial Medication Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Antimalarial Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Antimalarial Medication Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 GlaxoSmithKline
  26. 7.5.1 GlaxoSmithKline Company Information
  27. 7.5.2 GlaxoSmithKline Business Overview
  28. 7.5.3 GlaxoSmithKline Antimalarial Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Antimalarial Medication Product Portfolio
  30. 7.5.5 GlaxoSmithKline Recent Developments
  31. 7.6 F. Hoffmann-La Roche
  32. 7.6.1 F. Hoffmann-La Roche Company Information
  33. 7.6.2 F. Hoffmann-La Roche Business Overview
  34. 7.6.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 F. Hoffmann-La Roche Antimalarial Medication Product Portfolio
  36. 7.6.5 F. Hoffmann-La Roche Recent Developments
8 North America
  1. 8.1 North America Antimalarial Medication Market Size by Type
  2. 8.1.1 North America Antimalarial Medication Revenue by Type (2021-2032)
  3. 8.1.2 North America Antimalarial Medication Sales by Type (2021-2032)
  4. 8.1.3 North America Antimalarial Medication Price by Type (2021-2032)
  5. 8.2 North America Antimalarial Medication Market Size by Application
  6. 8.2.1 North America Antimalarial Medication Revenue by Application (2021-2032)
  7. 8.2.2 North America Antimalarial Medication Sales by Application (2021-2032)
  8. 8.2.3 North America Antimalarial Medication Price by Application (2021-2032)
  9. 8.3 North America Antimalarial Medication Market Size by Country
  10. 8.3.1 North America Antimalarial Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antimalarial Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antimalarial Medication Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Antimalarial Medication Market Size by Type
  2. 9.1.1 Europe Antimalarial Medication Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antimalarial Medication Sales by Type (2021-2032)
  4. 9.1.3 Europe Antimalarial Medication Price by Type (2021-2032)
  5. 9.2 Europe Antimalarial Medication Market Size by Application
  6. 9.2.1 Europe Antimalarial Medication Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antimalarial Medication Sales by Application (2021-2032)
  8. 9.2.3 Europe Antimalarial Medication Price by Application (2021-2032)
  9. 9.3 Europe Antimalarial Medication Market Size by Country
  10. 9.3.1 Europe Antimalarial Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antimalarial Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antimalarial Medication Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Antimalarial Medication Market Size by Type
  2. 10.1.1 China Antimalarial Medication Revenue by Type (2021-2032)
  3. 10.1.2 China Antimalarial Medication Sales by Type (2021-2032)
  4. 10.1.3 China Antimalarial Medication Price by Type (2021-2032)
  5. 10.2 China Antimalarial Medication Market Size by Application
  6. 10.2.1 China Antimalarial Medication Revenue by Application (2021-2032)
  7. 10.2.2 China Antimalarial Medication Sales by Application (2021-2032)
  8. 10.2.3 China Antimalarial Medication Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antimalarial Medication Market Size by Type
  2. 11.1.1 Asia Antimalarial Medication Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antimalarial Medication Sales by Type (2021-2032)
  4. 11.1.3 Asia Antimalarial Medication Price by Type (2021-2032)
  5. 11.2 Asia Antimalarial Medication Market Size by Application
  6. 11.2.1 Asia Antimalarial Medication Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antimalarial Medication Sales by Application (2021-2032)
  8. 11.2.3 Asia Antimalarial Medication Price by Application (2021-2032)
  9. 11.3 Asia Antimalarial Medication Market Size by Country
  10. 11.3.1 Asia Antimalarial Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antimalarial Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antimalarial Medication Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antimalarial Medication Market Size by Type
  2. 12.1.1 SAMEA Antimalarial Medication Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antimalarial Medication Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antimalarial Medication Price by Type (2021-2032)
  5. 12.2 SAMEA Antimalarial Medication Market Size by Application
  6. 12.2.1 SAMEA Antimalarial Medication Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antimalarial Medication Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antimalarial Medication Price by Application (2021-2032)
  9. 12.3 SAMEA Antimalarial Medication Market Size by Country
  10. 12.3.1 SAMEA Antimalarial Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antimalarial Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antimalarial Medication Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antimalarial Medication Value Chain Analysis
  2. 13.1.1 Antimalarial Medication Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antimalarial Medication Production Mode & Process
  6. 13.2 Antimalarial Medication Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antimalarial Medication Distributors
  9. 13.2.3 Antimalarial Medication Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst